Paralytic poliomyelitis: seasoned strategies, disappearing disease
The DOI matches its Crossref record; 27 of the 29 references it cites were found in a registry or an index.
Abstract
With more than 2 years having elapsed since the last case of paralytic poliomyelitis occurred in the Western Hemisphere, significant progress has been made towards the global eradication of wild polioviruses. Poliomyelitis is disappearing from Europe, North Africa, Southern Africa, the Middle East, China, and the Pacific. Reported poliomyelitis cases declined to 15,587 cases in 1992. Current eradication strategies recommended by the World Health Organization include national mass campaigns administering oral poliovaccine to all children under 5 years of age, enhanced surveillance to detect cases of acute flaccid paralysis, creating a network of laboratories for viral diagnosis, and targeted immunisation to areas and populations where poliovirus transmission is likely to persist. The major obstacles to eradication include inadequate political support for eradication and insufficient funding, especially for the purchase of vaccine. With additional support for the international eradication effort, epidemics of poliomyelitis will cease in developing countries, and industrialised countries will be able to save the large sums spent each year on poliovaccine and rehabilitation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When the GPEI began, polio was endemic on all continents, affecting 125 countries with an estimated 350,000 cases per year and causing 5–10% mortality (Figure 2a).”
From The Fight against Poliovirus Is Not Over (2023) · cites this paper as [60]
In the citing paper
“The basic strategy of the PEI is ( a ) high routine immunization coverage of infants with OPV, ( b ) supplementary OPV immunization through NIDs and SNIDs, ( c ) targeted doorto-door 'mop-up' OPV immunization in areas of focal transmission, and ( d ) sensitive surveillance for poliovirus (80).”
From VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION (2005) · cites this paper as [80]
In the citing paper
“While the original plan for global polio eradication envisioned a straightforward endgame strategy (80), that phase has become far more complex in view of the risks presented by VDPVs.”
From VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION (2005) · cites this paper as [80]
Citations
Cites
Field evaluation of vaccine efficacy.
Orenstein, W. A., Bernier, R. H., Tj, D., Hinman, A. R., Js, M., Bart, K. J., & Sirotkin, B. (1985) · Europe PMC (PubMed Central) · Cited by 621
Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: Review.
Patriarca, P. A., Wright, P. F., & John, T. J. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.5.926 · Cited by 453
Strebel, P. M., Sutter, R. W., Cochi, S. L., Biellik, R. J., Brink, E. W., Kew, O. M., Pallansch, M. A., Orenstein, W. A., & Hinman, A. R. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.568 · Cited by 337
Mucosal Immunity Induced by Enhanced-Potency Inactivated and Oral Polio Vaccines
Onorato, I. M., Modlin, J. F., McBean, A. M., Thoms, M. L., Losonsky, G. A., & Bernier, R. H. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.1.1 · Cited by 246
Melnick, J. L. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s387 · Cited by 168
de Quadrós, C. A., Andrus, J. K., Olive, J. I., da Silveira, C. M., EIKHOF, R. M., Carrasco, P., Fitzsimmons, J. W., & Pinheiro, F. P. (1991) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199103000-00011 · Cited by 137
SEROLOGIC RESPONSE TO ORAL POLIO VACCINE AND ENHANCED-POTENCY INACTIVATED POLIO VACCINES
McBEAN, A. M., THOMS, M. L., ALBRECHT, P., CUTHIE, J. C., BERNIER, R., & THE FIELD STAFF AND COORDINATING COMMITTEE (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115009 · Cited by 129
Antibody response of infants in tropics to five doses of oral polio vaccine.
John, T. J. (1976) · BMJ · doi:10.1136/bmj.1.6013.812 · Cited by 107
Sutter, R. W., PATRIARCA, P. A., Cochi, S. L., Pallansch, M. A., Kew, O. M., Hall, D. B., BROGAN, S., Malankar, P., AL-GHASSANI, A. A. K., Suleiman, A. J. M., et al. (1991) · The Lancet · doi:10.1016/0140-6736(91)91442-w · Cited by 102
Research works printed but not linked: 8
- Sabin, 1980, Vaccination against poliomyelitis in economically underdeveloped countries, Bull WHO, 58, 141
- 1992, Wkly Epidemiol Rec, 67, 336
- 1993, Wkly Epidemiol Rec, 68, 222
- 1993, Wkly Epidimiol Rec, 68, 297
- 1992, Wkly Epidemiol Rec, 67, 341
- PAHO, 1993, Strategies for the certification of the eradicaton of wild poliovirus transmission in the Americas, Bull PAHO, 27, 287
- Health and Welfare Canada, 1993, Preliminary report: wild poliovirus isolated in Alberta, 1993, Can Commun Dis Rep, 19, 57
- Mandke, 1990, Review of poliomyelitis in Bombay (1982-1989): observations on the improved immunization coverage, Indian J Publ Hlth, 34, 200
Cited by
The Mathematics of Infectious Diseases
Hethcote, H. W. (2000) · SIAM Review · doi:10.1137/s0036144500371907 · Cited by 6,687
Silver Nanoparticles as Potential Antiviral Agents
Galdiero, S., Falanga, A., Vitiello, M., Cantisani, M., Marra, V., & Galdiero, M. (2011) · Molecules · doi:10.3390/molecules16108894 · Cited by 963
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION
Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R., & Pallansch, M. A. (2005) · Annual Review of Microbiology · doi:10.1146/annurev.micro.58.030603.123625 · Cited by 703
Social Transfer of Pathogenic Fungus Promotes Active Immunisation in Ant Colonies
Konrad, M., Vyleta, M. L., Theis, F. J., Stock, M., Tragust, S., Klatt, M., Drescher, V., Marr, C., Ugelvig, L. V., & Cremer, S. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001300 · Cited by 247
Kilpatrick, D. R., Nottay, B., Yang, C. F., Yang, S. J., Mulders, M. N., Holloway, B. P., Pallansch, M. A., & Kew, O. M. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.12.2990-2996.1996 · Cited by 172
Metadata
- Authors
- Hull, H. F., Ward, N. A., Hull, B. P., Milstien, J. B., Hull, H. F., & de Quadros, C.
- Affiliations
- World Health Organization (CH)
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1994-05
- Volume
- 343
- Issue
- 8909
- Pages
- 1331-1337
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2060195907
- Cited by
- 235
- References
- 29
- Citations by year
- 2025: 4 · 2024: 4 · 2023: 6 · 2022: 1 · 2021: 7 · 2020: 2 · 2019: 4 · 2018: 1 · 2017: 5 · 2016: 4 · 2015: 4 · 2014: 7 · 2013: 5 · 2012: 12
- FWCI
- 19.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- paralytic poliomyelitis, polio eradication, acute flaccid paralysis surveillance, polio surveillance, wild poliovirus
- MeSH terms
- Humans, Poliomyelitis, Poliovirus Vaccine, Oral, Population Surveillance, Global Health, Immunization Programs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Paralytic poliomyelitis: seasoned strategies, disappearing disease. https://app.cochat.ai/papers/10.1016/s0140-6736(94)92472-4
- The paper
- Hull, H. F., Ward, N. A., Hull, B. P., Milstien, J. B., Hull, H. F., & de Quadros, C. (1994). Paralytic poliomyelitis: seasoned strategies, disappearing disease. The Lancet. https://doi.org/10.1016/s0140-6736(94)92472-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.